Fingerprint
Dive into the research topics of 'Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: The alternative dosing for outpatient treatment (ADOPT) trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically